$AUID
authID Inc.

2024 Q3 Form 10-Q Financial Statement

#000121390024066615 Filed on August 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2 2023 Q4
Revenue $248.9K $300.0K $71.90K
YoY Change 522.3% 650.0% -72.96%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.103M $2.169M $2.170M
YoY Change -29.21% 12.73% -29.85%
% of Gross Profit
Research & Development $1.616M $1.392M $1.134M
YoY Change 115.55% 74.82% -28.23%
% of Gross Profit
Depreciation & Amortization $43.80K $44.00K $255.9K
YoY Change -27.0% -42.12% 240.87%
% of Gross Profit
Operating Expenses $3.762M $3.605M $3.347M
YoY Change -0.35% 28.92% -29.52%
Operating Profit -$3.513M -$3.325M
YoY Change -5.86% 20.49%
Interest Expense $148.6K $63.59K -$13.14K
YoY Change 1031.07% -122.54% -101.89%
% of Operating Profit
Other Income/Expense, Net $148.6K $63.59K $67.56K
YoY Change 807.57% -99.15% 3897.63%
Pretax Income -$3.365M -$3.261M -$3.221M
YoY Change -9.44% -70.07% -46.43%
Income Tax -$390.00
% Of Pretax Income
Net Earnings -$3.400M -$3.261M -$3.220M
YoY Change -8.11% -69.46% -46.52%
Net Earnings / Revenue -1365.9% -1087.08% -4478.89%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.31 -$0.34 -$0.38
COMMON SHARES
Basic Shares Outstanding 10.92M shares 9.450M shares 7.875M shares
Diluted Shares Outstanding 10.92M shares 9.502M shares

Balance Sheet

Concept 2024 Q3 2024 Q2 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $11.72M $14.41M $10.18M
YoY Change 207.57% 140.85% 214.39%
Cash & Equivalents $11.72M $14.41M $10.18M
Short-Term Investments
Other Short-Term Assets $686.4K $771.8K $476.0K
YoY Change 44.75% -0.15% -34.74%
Inventory
Prepaid Expenses
Receivables $223.6K $192.7K $91.28K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $13.07M $15.73M $10.90M
YoY Change 197.09% 131.43% 150.8%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill $4.183M $4.183M $4.183M
YoY Change 0.0% 0.0% 0.0%
Intangibles $213.4K $255.2K $327.0K
YoY Change -42.4% -38.4% -42.25%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $4.397M $4.438M $4.510M
YoY Change -3.45% -3.46% -10.29%
TOTAL ASSETS
Total Short-Term Assets $13.07M $15.73M $10.90M
Total Long-Term Assets $4.397M $4.438M $4.510M
Total Assets $17.47M $20.17M $15.41M
YoY Change 95.11% 77.01% 64.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $511.5K $494.5K $339.8K
YoY Change 18.94% -43.23% -45.46%
Accrued Expenses $797.9K $828.6K $1.069M
YoY Change 42.49% 130.36% 101.37%
Deferred Revenue $330.0K $240.0K $131.6K
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $236.8K $232.7K
YoY Change
Total Short-Term Liabilities $1.876M $1.846M $1.665M
YoY Change 71.66% 43.13% 33.27%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $224.4K
YoY Change -100.0% -100.0% -97.14%
Other Long-Term Liabilities $0.00 $0.00 $325.0K
YoY Change -100.0% -100.0%
Total Long-Term Liabilities $0.00 $0.00 $549.4K
YoY Change -100.0% -100.0% -92.99%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.876M $1.846M $1.665M
Total Long-Term Liabilities $0.00 $0.00 $549.4K
Total Liabilities $1.876M $1.846M $2.214M
YoY Change 14.51% 0.82% -75.64%
SHAREHOLDERS EQUITY
Retained Earnings -$169.2M -$165.8M -$159.5M
YoY Change 8.25% 6.28% 13.82%
Common Stock $184.8M $184.2M $172.7M
YoY Change 12.95% 23430654.45% 23.14%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $15.59M $18.32M $13.20M
YoY Change
Total Liabilities & Shareholders Equity $17.47M $20.17M $15.41M
YoY Change 95.11% 77.01% 64.41%

Cashflow Statement

Concept 2024 Q3 2024 Q2 2023 Q4
OPERATING ACTIVITIES
Net Income -$3.400M -$3.261M -$3.220M
YoY Change -8.11% -69.46% -46.52%
Depreciation, Depletion And Amortization $43.80K $44.00K $255.9K
YoY Change -27.0% -42.12% 240.87%
Cash From Operating Activities -$2.700M -$2.800M -$2.150M
YoY Change -228.57% 39.99% -27.69%
INVESTING ACTIVITIES
Capital Expenditures $2.000K $15.58K -$3.400K
YoY Change -90.0% 257.89%
Acquisitions
YoY Change
Other Investing Activities $1.750K
YoY Change
Cash From Investing Activities -$2.000K -$15.58K -$4.850K
YoY Change -102.5% -605.21%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 40.00K 10.00M 8.515M
YoY Change -166.67% 56.67% -1386.21%
NET CHANGE
Cash From Operating Activities -$2.700M -$2.800M -2.150M
Cash From Investing Activities -2.000K -15.58K -4.850K
Cash From Financing Activities 40.00K 10.00M 8.515M
Net Change In Cash -$2.700M -$2.800M 6.360M
YoY Change -228.57% -163.88% -274.99%
FREE CASH FLOW
Cash From Operating Activities -$2.700M -$2.800M -$2.150M
Capital Expenditures $2.000K $15.58K -$3.400K
Free Cash Flow -$2.702M -$2.816M -$2.147M
YoY Change -229.9% 40.77% -27.78%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
usd
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
us-gaap Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation
DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation
usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.34
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.67
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40747
dei Entity Registrant Name
EntityRegistrantName
authID Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-2069547
dei Entity Address Address Line1
EntityAddressAddressLine1
1580 North Logan Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 660, Unit 51767
dei Entity Address City Or Town
EntityAddressCityOrTown
Denver
dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80203
dei City Area Code
CityAreaCode
516
dei Local Phone Number
LocalPhoneNumber
274-8700
dei Security12b Title
Security12bTitle
Common Stock par value $0.0001 per share
dei Trading Symbol
TradingSymbol
AUID
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
10920851 shares
CY2024Q2 us-gaap Cash
Cash
14407393 usd
CY2023Q4 us-gaap Cash
Cash
10177099 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
192667 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
91277 usd
CY2024Q2 us-gaap Deferred Costs Current
DeferredCostsCurrent
156735 usd
CY2023Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
157300 usd
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
771755 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
476004 usd
CY2024Q2 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
201610 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
15730160 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
10901680 usd
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
255171 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
327001 usd
CY2024Q2 us-gaap Goodwill
Goodwill
4183232 usd
CY2023Q4 us-gaap Goodwill
Goodwill
4183232 usd
CY2024Q2 us-gaap Assets
Assets
20168563 usd
CY2023Q4 us-gaap Assets
Assets
15411913 usd
CY2024Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
998040 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1408965 usd
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
243772 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
131628 usd
CY2024Q2 auid Commission Liability
CommissionLiability
46612 usd
CY2023Q4 auid Commission Liability
CommissionLiability
124150 usd
CY2024Q2 auid Accrued Severance Liability Current
AccruedSeveranceLiabilityCurrent
325000 usd
CY2024Q2 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
232654 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1846078 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1664743 usd
CY2023Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
224424 usd
CY2023Q4 auid Accrued Severance Liability
AccruedSeveranceLiability
325000 usd
CY2024Q2 us-gaap Liabilities
Liabilities
1846078 usd
CY2023Q4 us-gaap Liabilities
Liabilities
2214167 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10920851 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10920851 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9450220 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9450220 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
1092 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
945 usd
CY2024Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
184164638 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
172714712 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-165849353 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-159530535 usd
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
6108 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
12624 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
18322485 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
13197746 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
20168563 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15411913 usd
CY2024Q2 us-gaap Revenues
Revenues
280438 usd
CY2023Q2 us-gaap Revenues
Revenues
37142 usd
us-gaap Revenues
Revenues
437816 usd
us-gaap Revenues
Revenues
74998 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2169160 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2016908 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4231521 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2839662 usd
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1392103 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
703590 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2597071 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
824228 usd
CY2024Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
44004 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
76019 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
87412 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
152036 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
3605267 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
2796517 usd
us-gaap Operating Expenses
OperatingExpenses
6916004 usd
us-gaap Operating Expenses
OperatingExpenses
3815926 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3324829 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2759375 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-6478188 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3740928 usd
CY2024Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
10369 usd
CY2023Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
282109 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
23507 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
1082182 usd
CY2024Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
73957 usd
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
1160 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
182877 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
1160 usd
CY2023Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-380741 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-380741 usd
CY2023Q2 us-gaap Other Noncash Expense
OtherNoncashExpense
7476000 usd
us-gaap Other Noncash Expense
OtherNoncashExpense
7476000 usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
63588 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-8137690 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
159370 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-8937763 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3261241 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10897065 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6318818 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12678691 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3255 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3255 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-3261241 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-10900320 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-6318818 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-12681946 usd
CY2023Q2 us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
5694 usd
us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
3439 usd
CY2023Q2 us-gaap Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation
DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation
-216069 usd
us-gaap Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation
DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation
-216069 usd
CY2023Q2 us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
221763 usd
us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
219508 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-3261241 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-10678557 usd
us-gaap Net Income Loss
NetIncomeLoss
-6318818 usd
us-gaap Net Income Loss
NetIncomeLoss
-12462438 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.34
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-2.16
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.67
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-3.09
CY2023Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.04
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.05
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9501691 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5046514 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9475956 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4108372 shares
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-3261241 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-10678557 usd
us-gaap Net Income Loss
NetIncomeLoss
-6318818 usd
us-gaap Net Income Loss
NetIncomeLoss
-12462438 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-10594 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-132071 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-6516 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-156137 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3271835 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10810628 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6325334 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12618575 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
10867218 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
725704 usd
CY2024Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10001398 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-3261241 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-10594 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
18322485 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
13197746 usd
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1448675 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10001398 usd
us-gaap Net Income Loss
NetIncomeLoss
-6318818 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-6516 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
18322485 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-3900576 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1055690 usd
CY2023Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
438000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
165151 usd
CY2023Q2 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
15332011 usd
CY2023Q2 auid Conversion Of Credit Facility Borrowings Into Common Stock
ConversionOfCreditFacilityBorrowingsIntoCommonStock
900000 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6383641 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-10678557 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-132071 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
9563289 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
283536 usd
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
-1542902 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
438000 usd
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
387578 usd
us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
15332011 usd
auid Conversion Of Credit Facility Borrowings Into Common Stock
ConversionOfCreditFacilityBorrowingsIntoCommonStock
900000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6383641 usd
us-gaap Net Income Loss
NetIncomeLoss
-12462438 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-156137 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
9563289 usd
us-gaap Net Income Loss
NetIncomeLoss
-6318818 usd
us-gaap Net Income Loss
NetIncomeLoss
-12462438 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1448675 usd
us-gaap Share Based Compensation
ShareBasedCompensation
-1542902 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
87412 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
152036 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
8230 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
689305 usd
auid Noncash Recruiting Fees
NoncashRecruitingFees
438000 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
387578 usd
us-gaap Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation
DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation
-216069 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-380741 usd
us-gaap Other Noncash Expense
OtherNoncashExpense
7476000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
101390 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-219684 usd
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
76973 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
497379 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
136564 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-411552 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
63546 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
112144 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-22211 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
290000 usd
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
0 usd
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
110064 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5749651 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4173230 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
15582 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15582 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
10001398 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6383641 usd
us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
543760 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10001398 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6927401 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-5871 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-12206 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4230294 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2741965 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10177099 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3237106 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
2703 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14407393 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5981773 usd
us-gaap Interest Paid Net
InterestPaidNet
15276 usd
us-gaap Interest Paid Discontinued Operations
InterestPaidDiscontinuedOperations
364 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3255 usd
auid Cash Paid For Income Taxes Discontinued Operations
CashPaidForIncomeTaxesDiscontinuedOperations
1254 usd
auid Conversion Of Convertible Note Payable And Accrued Interest To Common Stock
ConversionOfConvertibleNotePayableAndAccruedInterestToCommonStock
7856011 usd
auid Conversion Of Credit Facility Borrowings Into Common Stock
ConversionOfCreditFacilityBorrowingsIntoCommonStock
900000 usd
auid Warrants For Services With The Sale Of Common Stock
WarrantsForServicesWithTheSaleOfCommonStock
877392 usd
auid Warrants For Services With The Sale Of Common Stock
WarrantsForServicesWithTheSaleOfCommonStock
725889 usd
auid Cashless Option And Warrant Exercises
CashlessOptionAndWarrantExercises
1 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-165800000 usd
CY2024Q2 us-gaap Revenues
Revenues
300000 usd
us-gaap Revenues
Revenues
400000 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2800000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5700000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-3300000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-6300000 usd
auid Increase In Working Capital Amount
IncreaseInWorkingCapitalAmount
10000000 usd
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Reclassification</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain prior year expenses have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the previously reported loss from continuing operations and management does not believe that this reclassification is material to the consolidated financial statements taken as a whole. Specifically, for the three and six months ended June 30, 2023, we reclassified approximately $64,000 and $93,000, respectively, in expenses from research and development expenses to general and administrative expenses.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023Q2 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
64000 usd
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
93000 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2558542 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2067242 shares
CY2024Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
244000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
132000 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Concentration of Revenue and Accounts Receivable</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the six months ended June 30, 2024, two customers represented 59% of revenue, respectively. For the six months ended June 30, 2023, one customer represented 47% of revenue. For the three months ended June 30, 2024, three customers represented 76% of revenue, respectively. For the three months ended June 30, 2023, one customer represented 51% of revenue. As of June 30, 2024, three customers accounted for 80% respectively, of accounts receivable. As of December 31, 2023, two customers accounted for 67%, respectively, of accounts receivable.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
4240000 usd
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
240000 usd
auid Non Cancellable Contracted Amounts
NonCancellableContractedAmounts
4000000 usd
CY2024Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.36 pure
CY2023Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
157300 usd
auid Increase Decrease Capitalized Contract Cost
IncreaseDecreaseCapitalizedContractCost
8294 usd
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
8859 usd
CY2024Q2 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
156735 usd
CY2024Q2 us-gaap Prepaid Insurance
PrepaidInsurance
310205 usd
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
184492 usd
CY2024Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
461550 usd
CY2023Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
291512 usd
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
771755 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
476004 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
327001 usd
us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
15582 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
87412 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
255171 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1914858 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1659687 usd
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
255171 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
87595 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
70889 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
20786 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
18019 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
18019 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
39863 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
255171 usd
CY2024Q2 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
248907 usd
CY2023Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
235606 usd
CY2024Q2 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
97168 usd
CY2023Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
707317 usd
CY2024Q2 us-gaap Accrued Insurance Current And Noncurrent
AccruedInsuranceCurrentAndNoncurrent
245542 usd
CY2023Q4 us-gaap Accrued Insurance Current And Noncurrent
AccruedInsuranceCurrentAndNoncurrent
104226 usd
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
406423 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
361816 usd
CY2024Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
998040 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1408965 usd
CY2024Q2 us-gaap Share Price
SharePrice
7.78
CY2024Q1 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
12500 shares
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
782 shares
CY2024Q2 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
117000 usd
us-gaap Fee Income
FeeIncome
70000 usd
CY2024Q2 us-gaap Other Expenses
OtherExpenses
285000 usd
us-gaap Other Expenses
OtherExpenses
542000 usd
CY2023Q2 us-gaap Other Expenses
OtherExpenses
67000 usd
us-gaap Other Expenses
OtherExpenses
99000 usd
CY2023Q3 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
25000 shares
CY2023Q3 us-gaap Share Price
SharePrice
7.36
CY2023Q4 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
4000 shares
CY2023Q4 us-gaap Share Price
SharePrice
9.25
us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
148000 usd
CY2024Q2 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
12254 shares
CY2024Q2 auid Performance Contributions Aggregate Amount
PerformanceContributionsAggregateAmount
100000 usd
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1464965 shares
CY2024Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
11000000 usd
CY2024Q2 us-gaap Deferred Offering Costs
DeferredOfferingCosts
10000000 usd
CY2023Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1989676 shares
CY2023Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
7300000 usd
CY2023Q2 us-gaap Deferred Offering Costs
DeferredOfferingCosts
6400000 usd
CY2023Q2 us-gaap Line Of Credit Facility Annual Principal Payment
LineOfCreditFacilityAnnualPrincipalPayment
900000 usd
CY2023Q2 us-gaap Stock Issued During Period Shares Conversion Of Units
StockIssuedDuringPeriodSharesConversionOfUnits
245634 shares
CY2023Q2 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
2348347 shares
CY2023Q2 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
7900000 usd
CY2023Q2 us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
7500000 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1796743 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
25.2
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y6M
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3630733 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
113282 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
9.19
auid Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm1
P10Y
auid Share Based Compensation Arrangement By Share Based Payment Award Options Grant In Period Grant Date Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantInPeriodGrantDateIntrinsicValue
15540 usd
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
15625 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
5.48
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
41581 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
24.88
auid Sharebased Compensation Arrangement By Sharebased Payment Award Options Weighted Average Contractual Life Forfeitedcancelled
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWeightedAverageContractualLifeForfeitedcancelled
P6Y6M
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1852819 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
24.43
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y2M12D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
4583031 usd
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1227820 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
29.32
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y1M6D
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2422237 usd
CY2024Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
1852819 shares
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P6Y2M12D
CY2024Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
1227820 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
395000 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
444115 shares
auid Total Annual Compensation Equal
TotalAnnualCompensationEqual
125000 usd
auid Annual Cash Compensation
AnnualCashCompensation
8000 usd
auid Outstanding Compensation Payable In Quarterly
OutstandingCompensationPayableInQuarterly
10000 usd
auid Annual Equity Compensation
AnnualEquityCompensation
117000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Terms Of Award
ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward
10 years
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
15627 shares
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 auid Accrued Severance Liability Current
AccruedSeveranceLiabilityCurrent
usd
CY2023Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
usd
CY2024Q2 auid Accrued Severance Liability
AccruedSeveranceLiability
usd
CY2024Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2024Q2 us-gaap Other Noncash Expense
OtherNoncashExpense
usd
us-gaap Other Noncash Expense
OtherNoncashExpense
usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2024Q2 us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
usd
us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
usd
CY2024Q2 us-gaap Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation
DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation
usd
CY2024Q2 us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
usd
us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-2.16
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-3.09
CY2024Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.05
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4108372 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5046514 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9475956 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9501691 shares
auid Noncash Recruiting Fees
NoncashRecruitingFees
usd
us-gaap Paid In Kind Interest
PaidInKindInterest
usd
us-gaap Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation
DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation
usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
us-gaap Other Noncash Expense
OtherNoncashExpense
usd
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Discontinued Operations
InterestPaidDiscontinuedOperations
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
auid Cash Paid For Income Taxes Discontinued Operations
CashPaidForIncomeTaxesDiscontinuedOperations
usd
auid Conversion Of Convertible Note Payable And Accrued Interest To Common Stock
ConversionOfConvertibleNotePayableAndAccruedInterestToCommonStock
usd
auid Conversion Of Credit Facility Borrowings Into Common Stock
ConversionOfCreditFacilityBorrowingsIntoCommonStock
usd
auid Cashless Option And Warrant Exercises
CashlessOptionAndWarrantExercises
usd
auid Sharebased Compensation Arrangement By Sharebased Payment Award Options Weighted Average Contractual Life Exercised
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWeightedAverageContractualLifeExercised
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
usd
auid Sharebased Compensation Arrangement By Sharebased Payment Award Options Aggregate Intrinsic Value Forfeitedcancelled
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAggregateIntrinsicValueForfeitedcancelled
usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001534154

Files In Submission

Name View Source Status
auid-20240630_cal.xml Edgar Link unprocessable
0001213900-24-066615-index-headers.html Edgar Link pending
0001213900-24-066615-index.html Edgar Link pending
0001213900-24-066615.txt Edgar Link pending
0001213900-24-066615-xbrl.zip Edgar Link pending
auid-20240630.xsd Edgar Link pending
ea0210135-10q_authid.htm Edgar Link pending
ea021013501ex31-1_authid.htm Edgar Link pending
ea021013501ex31-2_authid.htm Edgar Link pending
ea021013501ex32-1_authid.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
auid-20240630_def.xml Edgar Link unprocessable
auid-20240630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ea0210135-10q_authid_htm.xml Edgar Link completed
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
auid-20240630_lab.xml Edgar Link unprocessable